Education
About Us
Working with TipRanks
Follow Us
Thomas Jorg Heinrich Mehrling Insider Profile
4 Followers
Thomas Jorg Heinrich Mehrling, Chief Executive Officer, Ten Percent Owner at Helix BioPharma, holds 21.06M shares in Helix BioPharma (Ticker: TSE:HBP). Most recently, Thomas Jorg Heinrich Mehrling Bought 47,000 shares of Helix BioPharma on Jul 30, 2025 for an estimated value of C$46.87K.
Thomas Jorg Heinrich Mehrling Helix BioPharma (HBP)Chief Executive Officer, Ten Percent Owner
Helix BioPharma (HBP)
Chief Executive Officer, Ten Percent Owner
Ranked #20,512 out of 105,518 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+138.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Thomas Jorg Heinrich Mehrling's holdings
Insider Roles
Chief Executive Officer, Ten Percent Owner
Roles that Thomas Jorg Heinrich Mehrling holds in companies
Most Profitable Insider Trade
The most profitable trade made by Thomas Jorg Heinrich Mehrling
Thomas Jorg Heinrich Mehrling's Trading History
List of latest transactions for each holding click on a transaction to see Thomas Jorg Heinrich Mehrling's performance on stock
You May Also Like
Thomas Jorg Heinrich Mehrling insider profile FAQ
What is the percentage of profitable transactions made by Thomas Jorg Heinrich Mehrling?
The percentage of profitable transactions made by Thomas Jorg Heinrich Mehrling is 100%.
What is the average return per transaction made by Thomas Jorg Heinrich Mehrling?
The average return per transaction made by Thomas Jorg Heinrich Mehrling is 138.20%.
What stocks does Thomas Jorg Heinrich Mehrling hold?
Thomas Jorg Heinrich Mehrling holds: TSE:HBP stocks.
What was Thomas Jorg Heinrich Mehrling’s latest transaction?
Thomas Jorg Heinrich Mehrling latest transaction was an Informative Buy of C$46.87K.
What was Thomas Jorg Heinrich Mehrling's most profitable transaction?
Thomas Jorg Heinrich Mehrling’s most profitable transaction was an Informative Buy of TSE:HBP stock on May 23, 2025. The return on the trade was 150.00%.
What is Thomas Jorg Heinrich Mehrling's role in Helix BioPharma?
Thomas Jorg Heinrich Mehrling's role in Helix BioPharma is Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.